Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 287
Selected: 0
NCT IDTitle
NCT06342986Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT03297463Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
NCT00609739Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
NCT00748163Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
NCT00726739Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma
NCT01288222Selecting a Favorable KIR Donor in Unrelated HCT for AML
NCT00005986Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia
NCT00176839Stem Cell Transplantation for Hematological Malignancies
NCT06693986Adenovirus (RGDCRAdCOX2F)
NCT00784524Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca
NCT05708924MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT00265863Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites
NCT03998735Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure
NCT02042924Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
NCT01634217Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
NCT00618696Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
NCT00176865Stem Cell Transplant for Immunologic or Histiocytic Disorders
NCT05025774Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
NCT00357565Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
NCT00630565Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT06030648MT2022-01: MSCs for ALD
NCT01601548Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy
NCT00383448HSCT for High Risk Inherited Inborn Errors
NCT03314974Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT03642626MT2017-45: CAR-T Cell Therapy for Heme Malignancies
NCT02988466Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
NCT06295757Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT00319748Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
NCT00176826T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT00345865Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
NCT00003926Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
NCT00428194Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
NCT05338658Study of PAT in Patients With Solid Tumor Cancers
NCT00356941Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC
NCT00290641Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
NCT04090606Tobacco Constituents and Biomarkers
NCT00882206Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia
NCT00652899Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
NCT06692426Trial of Cell Based Therapy for DMD
NCT03152526CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
NCT03019666Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
NCT01666080Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
NCT00295880Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
NCT00625729Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
NCT00725062Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
NCT00369291CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
NCT04514029Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel